You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Paolo Cappella1, Fabio Gasparri
11Cell Biology Department, Oncology Business Unit, Nerviano Medical Sciences S.r.l., Nerviano, Italy.
This study introduces a novel six-marker high-content assay for phenotypic drug discovery (PDD). This advanced technique enhances cellular profiling and reveals phenotypic heterogeneity in drug response.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: